Carly M. Harro

998 total citations
11 papers, 92 citations indexed

About

Carly M. Harro is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carly M. Harro has authored 11 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Carly M. Harro's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Carly M. Harro is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Carly M. Harro collaborates with scholars based in United States, India and Brazil. Carly M. Harro's co-authors include José R. Conejo-García, Kyle K. Payne, Kristen E. Rigolizzo, Álvaro N.A. Monteiro, Alexandra Martin, Volha A. Golubeva, Subir Biswas, James T. Riordan, Lindsey N. Shaw and Giuliano Di Pietro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Carly M. Harro

10 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carly M. Harro United States 5 48 33 25 18 11 11 92
Courtney Tindle United States 5 41 0.9× 26 0.8× 21 0.8× 26 1.4× 7 0.6× 7 119
Brendan Veeneman United States 7 92 1.9× 18 0.5× 36 1.4× 16 0.9× 3 0.3× 9 180
Anne Luzius Germany 3 114 2.4× 26 0.8× 12 0.5× 25 1.4× 2 0.2× 5 154
Nitya V. Sharma United States 7 57 1.2× 18 0.5× 17 0.7× 7 0.4× 3 0.3× 8 145
Dhwani Patel United States 5 81 1.7× 7 0.2× 37 1.5× 8 0.4× 5 0.5× 9 142
Chiyo Sugawara Japan 4 59 1.2× 17 0.5× 19 0.8× 90 5.0× 35 3.2× 5 180
Adrian Baez‐Ortega United Kingdom 6 61 1.3× 15 0.5× 7 0.3× 4 0.2× 3 0.3× 9 110
Chi-Dung Yang Taiwan 7 89 1.9× 38 1.2× 15 0.6× 10 0.6× 14 1.3× 7 132
Bradley Garman United States 5 58 1.2× 95 2.9× 22 0.9× 10 0.6× 24 2.2× 7 170
A. M. Mahedi Hasan United Kingdom 6 98 2.0× 50 1.5× 10 0.4× 10 0.6× 7 0.6× 8 151

Countries citing papers authored by Carly M. Harro

Since Specialization
Citations

This map shows the geographic impact of Carly M. Harro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carly M. Harro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carly M. Harro more than expected).

Fields of papers citing papers by Carly M. Harro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carly M. Harro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carly M. Harro. The network helps show where Carly M. Harro may publish in the future.

Co-authorship network of co-authors of Carly M. Harro

This figure shows the co-authorship network connecting the top 25 collaborators of Carly M. Harro. A scholar is included among the top collaborators of Carly M. Harro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carly M. Harro. Carly M. Harro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mai, David, Carly M. Harro, A. Sanyal, et al.. (2024). Stem Loop Mediated Transgene Modulation in Human T Cells. ACS Synthetic Biology. 13(12). 3897–3907.
2.
Harro, Carly M., Kimberly B. Sprenger, Ricardo A. Chaurio, et al.. (2023). Sézary syndrome originates from heavily mutated hematopoietic progenitors. Blood Advances. 7(18). 5586–5602. 5 indexed citations
3.
Martin, Alexandra, Subir Biswas, Jessica A. Mine, et al.. (2023). Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 173. 114–121. 3 indexed citations
4.
Martin, Alexandra, Carmen M. Anadon, Subir Biswas, et al.. (2022). Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors. Molecular Cancer Therapeutics. 21(7). 1184–1194. 23 indexed citations
5.
Martin, Alexandra, Subir Biswas, Jessica A. Mine, et al.. (2022). Olfactory receptor OR5V1 is an effective target for CAR T cells in ovarian cancer (207). Gynecologic Oncology. 166. S116–S116. 1 indexed citations
6.
Biswas, Subir, Alexandra Martin, Jessica A. Mine, et al.. (2022). CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors. The Journal of Immunology. 208(Supplement_1). 117.16–117.16. 1 indexed citations
7.
Mendoza-Fandiño, Gustavo, Paulo C. Lyra, Carly M. Harro, et al.. (2021). Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics. 30(4). 465–473. 2 indexed citations
8.
Zhang, Yumeng, Lucia Seminario‐Vidal, Hien Liu, et al.. (2021). Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center. Leukemia & lymphoma. 63(1). 109–116. 3 indexed citations
9.
Harro, Carly M., Tara Lee Costich, Kyle K. Payne, et al.. (2020). Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. Journal of Clinical Investigation. 131(3). 9 indexed citations
10.
Golubeva, Volha A., Giuliano Di Pietro, Carly M. Harro, et al.. (2019). Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation. Journal of Biological Chemistry. 294(15). 5980–5992. 31 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Courtney Tindle Breakdown of academic impact, for papers by Brendan Veeneman Breakdown of academic impact, for papers by Anne Luzius Breakdown of academic impact, for papers by Nitya V. Sharma Breakdown of academic impact, for papers by Dhwani Patel Breakdown of academic impact, for papers by Chiyo Sugawara Breakdown of academic impact, for papers by Adrian Baez‐Ortega Breakdown of academic impact, for papers by Chi-Dung Yang Breakdown of academic impact, for papers by Bradley Garman Breakdown of academic impact, for papers by A. M. Mahedi Hasan
Rankless by CCL
2026